In the past one year, the Nifty Pharma Index has shed 12.4% as against the 1% gains in the benchmark Nifty 50. Mutual Funds that bet on pharma stocks have fallen 14.2% on an average in the past one year. So far in 2022, they have declined 12.4% on an average, according to Value Research.
Atul Suri bets on IT, pharma and FMCG for next six months
But the thing that really stands out for me at the moment are the things that I am working on, which takes up my time,